Mission-oriented biomedical research at the NIH

Research Policy

Volumn 41, Issue 10, 2012, Pages 1729-1741

  Sampat, Bhaven N ^a  

^a Columbia University ^*  (United States)

Author keywords

Medical research; Mission oriented research; NIH; Serendipity

Indexed keywords

ALLOCATION PROCESS; BIOMEDICAL RESEARCH; DEMAND-SIDE; MEDICAL RESEARCH; NATIONAL INSTITUTES OF HEALTH; NIH; PAPER DOCUMENTS; POLITICAL SUPPORT; RESEARCH POLICIES; SCIENCE MISSIONS; SCIENTIFIC RESEARCHES; SERENDIPITY;

HEALTH;

RESEARCH;

EID: 84870236707     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2012.05.013     Document Type: Article

References (68)

1. American Association for the Advancement of Science (AAAS), 2012. AAAS Report XXXVII: Research and Development FY2013 (downloaded on 17 September 2012 from http://www.aaas.org/spp/rd/rdreport2013/).
2. P. Azoulay, J. Graff Zivin, and G. Manso Incentives and creativity: evidence from the life sciences Rand Journal of Economics 42 2011 527 554
3. J. Bhattacharya, and M. Packalen Opportunities and benefits as determinants of the direction of scientific research Journal of Health Economics 30 2011 603 615
4. R. Brennan, S. Federico, and M. Dyer The war on cancer: have we won the battle but lost the war? Oncotarget 1 2010 77 83
5. H. Brooks The problem of research priorities Daedalus 107 1978 171 190
6. H. Brooks The evolution of U.S. science policy B.L.R. Smith, C.E. Barfield, Technology, R&D, and the Economy 1995 The Brookings Institution and American Enterprise Institute Washington, DC 15 48
7. L. Bryder Tuberculosis and the MR J. Austoker, L. Bryder, Historical Perspectives on the Role of the MRC 1989 Oxford University Press Oxford 1 22
8. V. Bush Science The Endless Frontier: A Report to the President 1945 Government Printing Office Washington, DC
9. D. Callahan What Price Better Health? Hazards of the Research Imperative 2003 University of California Press Berkeley and Los Angeles, CA
10. E. Check Biomedical research: facing the opposition Nature 441 2006 17 19
11. D. Chubin, and E. Hackett Peerless Science: Peer Review and U.S. Science Policy 1990 SUNY Press Albany, NY
12. R. Cook-Deegan, and M. McGeary The jewel in the federal crown? History, politics, and the National Institutes of Health R.A. Stevens, C.E. Rosenberg, L.R. Burns, History and Health Policy in the United States: Putting the Past Back 2006 Rutgers University Press Piscataway, NJ 176 201
13. Cohn, V., 1970. Multi-billion cancer war by a new agency urged; study urges separate cancer agency. Washington Post, December 5, 1970: A1-A2.
14. Cutler, D., Meara, E. Richards, S., 2009. Induced Innovation and Social Inequality: Evidence From Infant Medical Care. NBER Working Paper 15316.
15. J.M. Drazen, and J.R. Ingelfinger Grants, litics, and the NIH The New England Journal of Medicine 349 2003 2259 2261
16. E. Drew The health syndicate: Washington's noble conspirators Atlantic Monthly 220 1967 75 82
17. E.R. Dorsey, J. de Roulet, J.P. Thompson, J.I. Reminick, A. Thai, Z. White-Stellato, C.A. Beck, B.P. George, and H. Moses III Funding of US biomedical research 2003-2008 Journal of the American Medical Association 303 2010 137 143
18. P. Gorden, D.F. Cyphers, and C. Feld Budget trends and issues affecting biomedical research: a perspective from the National Institute of Diabetes and Digestive and Kidney Diseases Hepatology 18 1993 677 687
19. C.P. Gross, G.F. Anderson, and N.R. Powe The relation between funding by the National Institutes of Health and the burden of disease The New England Journal of Medicine 340 1999 1881 1887
20. V. Harden Inventing the NIH: Federal Biomedical Research Policy 1887-1937 1986 Johns Hopkins University Press Baltimore, MD
21. V. Harden AIDS at 30: A History 2012 Potomac Press Washington, DC
22. Harris Interactive. 2007. CDC, FAA, NIH, FDA, FBI and USDA Get the Highest Ratings of Thirteen Federal Government Agencies (downloaded on 17 September 2012 from http://www.harrisinteractive.com/vault/Harris-Interactive- Poll-Research-Government-Agencies-2007-02.pdf).
23. D. Hegde, and D. Mowery Politics and funding in the U.S. public biomedical R&D system Science 322 2007 1797 1798
24. Hegde, D., Sampat, B., 2011. The Political Economy of Publicly Funded Biomedical Research: Evidence from NIH Funding for Rare Diseases. Working paper (downloaded on 17 September 2012 from http://politics.as.nyu.edu/docs/IO/21318/ Hegde.pdf).
25. Institute of Medicine Scientific Opportunity and Public Needs: Improving Priority Setting and Public Input at the National Institutes of Health 1998 National Academies Press Washington, DC
26. Institute of Medicine NIH Extramural Center Programs: Criteria for Initiation and Evaluation 2004 National Academies Press Washington, DC
27. Johnson, J.A., 1998. Disease Funding and NIH Priority Setting. Congressional Research Service Report for Congress, Report 97-917. Congressional Research Service, Washington, DC.
28. J. Kaiser, E. Marshall, and L. Zahn An interview with Francis Collins at the NIH Science 328 2010 1090 1091
29. D. Kevles The national science foundation and the debate over postwar research policy Isis 68 1977 4 26
30. M. Kim, R.J. Blendon, and J.M. Benson How interested are Americans in new medical technologies?. A multicountry comparison Health Affairs 20 2001 194 201
31. F.R. Lichtenberg The allocation of publicly funded biomedical research E. Berndt, D. Cutler, Medical Care Output and Productivity 2001 Studies in Income and Wealth University of Chicago Press Chicago 565 589
32. M. Moran, J. Guzman, A.L. Ropars, A. McDonald, N. Jameson, B. Omune, S. Ryan, and L. Wu Neglected disease research and development: how much are we really spending? PLoS Medicine 6 2009 e1000030
33. P. Morlacchi, and R.R. Nelson How medical practice evolves: the case of the left ventricular assist device Research Policy 40 2010 511 525
34. H. Moses III, E.R. Dorsey, D.H.M. Matheson, and S.O. Their Financial anatomy of biomedical research Journal of the American Medical Association 294 2005 1333 1342
35. D.C. Mowery, R.R. Nelson, and B.R. Martin Technology policy and global warming: why new policy models are needed (or why putting new wine in old bottles won't work) Research Policy 3 2010 1011 1023
36. D. Mowery The Bush report after fifty years: blueprint or relic? C. Barfield, Science for the Twenty-First Century: The Bush Report Revisited. 1997 AEI Press Washington, DC 24 40
37. S. Mukherjee The Emperor of All Maladies: A Biography of Cancer 2010 Simon and Schuster New York
38. S. Mushkin Biomedical Research: Costs and Benefits 1979 Ballinger Publishing Cambridge, MA
39. National Institutes of Health Setting Research Priorities at the National Institutes of Health, NIH publication no. 97-4265 1997 National Institutes of Health Bethesda, MD
40. National Science Foundation (NSF), 2010. Science and Engineering Indicators 2010 (downloaded on 17 September 2012 from http://www.nsf.gov/ statistics/seind10/pdf/seind10.pdf).
41. OECD, 2007. Science, Technology, and Industry Scoreboard 2007: Innovation and Performance in the Global Economy.
42. R.A. Rettig Cancer Crusade: The Story of the National Cancer Act of 1971 1977 Princeton University Press Princeton, NJ
43. B. Sampat The dismal science, the crown jewel, and the endless frontier D. Foray, The New Economics of Technology Policy 2007 Edward Elgar Cheltenham, UK, Northampton, MA 148 162
44. B. Sampat The impact of publicly funded biomedical and health research: a review S. Olson, S. Merrill, Measuring the Impacts of Federal Investments in Research 2011 National Academy Press Washington, DC 153 192
45. Sampat, B., Buterbaugh, K., Perl, M., 2011. New Evidence on the Allocation of NIH Funds Across Disease Areas. Working Paper.
46. B. Schmidt Five years into the national cancer program The Yale Journal of Biology and Medicine 50 1977 237 244
47. J. Schmookler Catastrophe and utilitarianism in the development of basic science R. Tybout, Economics of Research and Development 1965 Ohio State University Press Columbus, OH 19 33
48. "Senators Doctor Kennedy and Hatch," Opinion Page, New York Times July 15, 1988.
49. W. Shapley The Budget Process and R&D 1992 Carnegie Commission on Science, Technology, and Government New York
50. P. Starr The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry 1984 Basic Books New York
51. D.E. Stokes Pasteur's Quadrant: Basic Science and Technological Innovation 1997 Brookings Institution Press Washington, DC
52. M.J. Straus The political history of the artificial heart New England Journal of Medicine 310 1984 332 336
53. S.P. Strickland Politics, Science, and Dread Disease: A Short History of United States Medical Research Policy 1972 Harvard University Press Cambridge, MA
54. S.P. Strickland Story of the NIH Grants Program 1989 University Press of America Lanham, MD
55. B. Tauzin The next 50 years of medical innovation has already started 2008 Pharmaceutical Research and Manufacturers of America Washington, DC
56. U.S. Government Accountability Office, 2009. National Institutes of Health: Completion of Comprehensive Risk Management Program Essential to Effective Oversight (downloaded on 17 September 2012 from http://www.gao.gov/ assets/300/295085.pdf).
57. U.S. National Academy of Sciences The Artificial Heart: Prototypes, Policies and Patients 1991 National Academy Press Washington, DC
58. U.S. National Research Council and Institute of Medicine Enhancing the Vitality of the National Institutes of Health 2003 National Academy Press Washington, DC
59. G. Weissman Is drug development too slow? NIH to the rescue! The FASEB Journal 25 2011 1119 1122
60. Varmus, H., 1997. Testimony on Setting Research Priorities at NIH before the House Committee on Appropriations, Subcommittee on Labor, HHS, Education.(downloaded on 17 September 2012 from http://www.hhs.gov/asl/testify/ t970610a.html).
61. Varmus, H., 1999. Statement on Funding Allocation for Disease Research Before the Senate Committee on Appropriations, Subcommittee on Labor, HHS, Education (downloaded on 17 September 2012 from http://www.hhs.gov/asl/testify/ t990506a.html).
62. H. Varmus Proliferation of National Institutes of Health Science 291 2001 1903 1905
63. H. Varmus The Art and Politics of Science 1st ed. 2009 W.W. Norton New York
64. M. Wadman Biomedical philanthropy: state of the donation Nature 447 2007 248 250
65. A. Wildavsky Political implications of budgetary reform Public Administration Review 21 1961 183 190
66. Zeckhauser, R., 1967. Some Thoughts on the Allocation of Resources to Bio-Medical Research. U.S. Department of Health, Education, and Welfare, Office of the Assistant for Planning and Evaluation, Occasional Paper No. 4, November 9.
67. E.A. Zerhouni NIH in the Post-Doubling Era: Realities, Strategies Science 2006 1088 1090
68. E. Zerhouni The NIH Roadmap Science 302 2003 63 72